Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 and Diabetic Clinical Trials

24.07.2023 - ALLEN, TX / ACCESSWIRE / July 24, 2023 / Enzolytics, Inc. (OTC PINK:ENZC) (https://enzolytics.com/).Virogentics, Inc. ('VIRO') a wholly owned subsidiary of Enzolytics, Inc. (the 'Company' or 'ENZC'), a drug development biotech company, announced ... Seite 1

Related Keywords

United Kingdom ,Bulgaria ,Addis Ababa ,T10 ,Ethiopia ,Bulgarian ,Scotland ,Harry Zhabiov ,Barry Kostiner ,Amogne Wondwossen ,European Medicine Agency ,University Of Dundee ,Medicine Department ,Ministry Of Health ,School Of Medicine ,Associate Professor ,Internal Medicine ,Addis Ababa University College ,Health Sciences ,Clinical Medicine ,Chief Scientific Officer ,Sagaliam Nasdaq ,Enzolytics ,